Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications,European Journal of Clinical Investigation

当前位置： X-MOL 学术 › Eur. J. Clin. Investig. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-08-14 , DOI: 10.1111/eci.13665
Giacomo Tini _{1,

2} , Eugenio Sessarego ₁ , Stefano Benenati ₁ , Pier Filippo Vianello ₁ , Beatrice Musumeci ₂ , Camillo Autore ₂ , Marco Canepa _{1,

3}

Affiliation

Transthyretin-related cardiac amyloidosis (TTR-CA) is thought to be particularly common in specific at-risk conditions, including aortic stenosis (AS), heart failure with preserved ejection fraction (HFpEF), carpal tunnel syndrome (CTS) and left ventricular hypertrophy or hypertrophic cardiomyopathy (LVH/HCM).

中文翻译：

不同条件下转甲状腺素蛋白相关心脏淀粉样变性的骨闪烁显像筛查结果：方法学问题和临床意义

转甲状腺素蛋白相关的心脏淀粉样变性 (TTR-CA) 被认为在特定的高危疾病中特别常见，包括主动脉瓣狭窄 (AS)、射血分数保留的心力衰竭 (HFpEF)、腕管综合征 (CTS) 和左心室肥大或肥厚型心肌病 (LVH/HCM)。

更新日期：2021-08-14

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11